The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease
Open accessAbstract
To our knowledge, this is one of the few studies thus far that correlates the composition of the gut microbiota with the direct analysis of fecal metabolites in patients with Parkinson’s disease. Overall, our data highlight microbiota modifications correlated with numerous fecal metabolites. This suggests that Parkinson’s disease is associated with gut dysregulation that involves a synergistic relationship between gut microbes and several bacterial metabolites favoring altered homeostasis. Interestingly, a reduction of short-chain fatty acid (SCFA)-producing bacteria influenced the shape of the metabolomics profile, affecting several metabolites with potential protective effects in the Parkinson group. On the other hand, the extensive impact that intestinal dysbiosis has at the level of numerous metabolic pathways could encourage the identification of specific biomarkers for the diagnosis and treatment of Parkinson’s disease, also in light of the effect that specific drugs have on the composition of the intestinal microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Dhariwal, A., Chong, J., Habib, S., King, I. L., Agellon, L. B., & Xia, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx295 · Cited by 1,885
Goetz, C. G., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stebbins, G. T., Stern, M. B., Tilley, B. C., Dodel, R., Dubois, B., et al. (2007) · Movement Disorders · doi:10.1002/mds.21198 · Cited by 1,404
Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354
Colonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281
Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.019 · Cited by 1,159
Links between diet, gut microbiota composition and gut metabolism
Flint, H. J., Duncan, S. H., Scott, K. P., & Louis, P. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s0029665114001463 · Cited by 1,020
Gastrointestinal Dysfunction in Parkinson’s Disease
Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., & Pfeiffer, R. F. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00007-1 · Cited by 1,016
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874
Frequency of Bowel Movements and the Future Risk of Parkinson’s Disease
Abbott, R. D., Petrovitch, H., White, L. R., Masaki, K. H., Tanner, C. M., Curb, J. D., Grandinetti, A., Blanchette, P. L., Popper, J. S., & Ross, G. W. (2001) · Neurology · doi:10.1212/wnl.57.3.456 · Cited by 839
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
Maini Rekdal, V., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J., & Balskus, E. P. (2019) · Science · doi:10.1126/science.aau6323 · Cited by 753
Bedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U. (2017) · Genome Medicine · doi:10.1186/s13073-017-0428-y · Cited by 642
Colonic inflammation in Parkinson's disease
Devos, D., Lebouvier, T., Lardeux, B., Biraud, M., Rouaud, T., Pouclet, H., Coron, E., Bruley des Varannes, S., Naveilhan, P., Nguyen, J.-M., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.09.007 · Cited by 627
A timeline for Parkinson's disease
Hawkes, C. H., Del Tredici, K., & Braak, H. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.08.007 · Cited by 594
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
Houser, M. C., & Tansey, M. G. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-016-0002-0 · Cited by 588
Brain-Gut-Microbiota Axis in Parkinson’s Disease
Mulak, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10609 · Cited by 583
Metabolism of Dietary and Microbial Vitamin B Family in the Regulation of Host Immunity
Yoshii, K., Hosomi, K., Sawane, K., & Kunisawa, J. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00048 · Cited by 570
Amino acid metabolism in intestinal bacteria: links between gut ecology and host health
Dai, Z.-L. (2011) · Frontiers in Bioscience · doi:10.2741/3820 · Cited by 564
Short-Chain Fatty Acids Regulate the Enteric Neurons and Control Gastrointestinal Motility in Rats
Soret, R., Chevalier, J., De Coppet, P., Poupeau, G., Derkinderen, P., Segain, J. P., & Neunlist, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.053 · Cited by 530
Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease
Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142164 · Cited by 523
van Kessel, S. P., Frye, A. K., El-Gendy, A. O., Castejon, M., Keshavarzian, A., van Dijk, G., & El Aidy, S. (2019) · Nature Communications · doi:10.1038/s41467-019-08294-y · Cited by 521
Analysis of Gut Microbiota in Patients with Parkinson’s Disease
Petrov, V. A., Saltykova, I. V., Zhukova, I. A., Alifirova, V. M., Zhukova, N. G., Dorofeeva, Y. B., Tyakht, A. V., Kovarsky, B. A., Alekseev, D. G., Kostryukova, E. S., et al. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3700-7 · Cited by 487
Li, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., Jin, F., & Qin, B. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9001-4 · Cited by 406
Santoru, M. L., Piras, C., Murgia, A., Palmas, V., Camboni, T., Liggi, S., Ibba, I., Lai, M. A., Orrù, S., Blois, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10034-5 · Cited by 387
Self-citationGut microbiota in Parkinson disease in a northern German cohort
Hopfner, F., Künstner, A., Müller, S. H., Künzel, S., Zeuner, K. E., Margraf, N. G., Deuschl, G., Baines, J. F., & Kuhlenbäumer, G. (2017) · Brain Research · doi:10.1016/j.brainres.2017.04.019 · Cited by 318
Pathological correlates of gastrointestinal dysfunction in Parkinson's disease
Cersosimo, M. G., & Benarroch, E. E. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.014 · Cited by 284
Identification of novel biomarkers for Parkinson's disease by metabolomic technologies
Hatano, T., Saiki, S., Okuzumi, A., Mohney, R. P., & Hattori, N. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309676 · Cited by 282
Gut microbiota in patients with Parkinson's disease in southern China
Lin, A., Zheng, W., He, Y., Tang, W., Wei, X., He, R., Huang, W., Su, Y., Huang, Y., Zhou, H., et al. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.05.007 · Cited by 253 · cited 1×
“In agreement and extending the results of another study (30) reporting a reduction of the Brevibacteriaceae family, we also found a decrease of the Brevibacterium genus.”
ResultThe Role of Lipids in Parkinson’s Disease
Xicoy, H., Wieringa, B., & Martens, G. J. M. (2019) · Cells · doi:10.3390/cells8010027 · Cited by 250
Contribution of the microflora to proteolysis in the human large intestine
Macfarlane, G. T., Allison, C., Gibson, S. A. W., & Cummings, J. H. (1988) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1988.tb02427.x · Cited by 237
The Influence of Nicotinamide on Health and Disease in the Central Nervous System
Fricker, R. A., Green, E. L., Jenkins, S. I., & Griffin, S. M. (2018) · International Journal of Tryptophan Research · doi:10.1177/1178646918776658 · Cited by 200
Kovács, T., Mikó, E., Vida, A., Sebő, É., Toth, J., Csonka, T., Boratkó, A., Ujlaki, G., Lente, G., Kovács, P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37664-7 · Cited by 187
Gut dysfunction in Parkinson's disease
Mukherjee, A., Biswas, A., & Das, S. K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i25.5742 · Cited by 171
Trupp, M., Jonsson, P., Öhrfelt, A., Zetterberg, H., Obudulu, O., Malm, L., Wuolikainen, A., Linder, J., Möritz, T., Blennow, K., et al. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-140389 · Cited by 146
Rivas, B. D. L., Marcobal, A. M., Carrascosa, A. V., & Múñoz, R. (2006) · Journal of Food Protection · doi:10.4315/0362-028x-69.10.2509 · Cited by 139
de Farias, C. C., Maes, M. H. J., Bonifácio, K. L., Bortolasci, C. C., Souza-Nogueira, A., Brinholi, F. F., Matsumoto, A. K., do Nascimento, M. A., de Melo, L. B., Nixdorf, S. L., et al. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.011 · Cited by 130
Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease
Trezzi, J., Galozzi, S., Jaeger, C., Barkovits, K., Brockmann, K., Maetzler, W., Berg, D., Marcus, K., Betsou, F., Hiller, K., et al. (2017) · Movement Disorders · doi:10.1002/mds.27132 · Cited by 126
Brenner, S. R. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2012.10.010 · Cited by 107
Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling
Zhao, H., Wang, C., Zhao, N., Li, W., Yang, Z., Liu, X., Le, W., & Zhang, X. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.01.025 · Cited by 102
Serum amino acid profile in patients with Parkinson’s disease
Figura, M., Kuśmierska, K., Bucior, E., Szlufik, S., Koziorowski, D., Jamrozik, Z., & Janik, P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191670 · Cited by 101
Lei, S., Zavala-Flores, L. M., García‐García, A., Nandakumar, R., Huang, Y., Madayiputhiya, N., Stanton, R. C., Dodds, E. D., Powers, R., & Franco, R. (2014) · ACS Chemical Biology · doi:10.1021/cb400894a · Cited by 99
Profiling novel metabolic biomarkers for Parkinson's disease using in‐depth metabolomic analysis
Han, W., Sapkota, S., Camicioli, R. M., Dixon, R. A., & Li, L. (2017) · Movement Disorders · doi:10.1002/mds.27173 · Cited by 98
Hernando, S., Requejo, C., Herrán, E., Ruíz-Ortega, J. Á., Morera‐Herreras, T., Lafuente, J. V., Ugedo, L., Gaínza, E., Pedraz, J. L., Igartúa, M., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.10.001 · Cited by 97
Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
Willkommen, D., Lucio, M., Moritz, F., Forcisi, S., Kanawati, B., Smirnov, K. S., Schroeter, M., Sigaroudi, A., Schmitt‐Kopplin, P., & Michalke, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208752 · Cited by 86
Patassini, S., Begley, P., Xu, J., Church, S. J., Kureishy, N., Reid, S. J., Waldvogel, H. J., Faull, R. L. M., Snell, R. G., Unwin, R. D., et al. (2019) · Metabolites · doi:10.3390/metabo9060113 · Cited by 82
B Vitamins and Fatty Acids: What Do They Share with Small Vessel Disease-Related Dementia?
Moretti, R., & Peinkhofer, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225797 · Cited by 62
Metabolomics‐based identification of metabolic alterations in PARK2
Okuzumi, A., Hatano, T., Ueno, S., Ogawa, T., Saiki, S., Mori, A., Koinuma, T., Oji, Y., Ishikawa, K., Fujimaki, M., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.724 · Cited by 55
Niacin Depletion in Parkinsonian Patients Treated with L-dopa, Benserazide and Carbidopa
Bender, D. A., Earl, C., & Lees, A. J. (1979) · Clinical Science · doi:10.1042/cs0560089 · Cited by 48
Alterations in Lipid and Inositol Metabolisms in Two Dopaminergic Disorders
Schulte, E. C., Altmaier, E., Berger, H. S., Do, K. T., Kastenmüller, G., Wahl, S., Adamski, J., Peters, A., Krumsiek, J., Suhre, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147129 · Cited by 44
Peripheral alpha‐synuclein and Parkinson's disease
Olanow, C. W., Wakeman, D. R., & Kordower, J. H. (2014) · Movement Disorders · doi:10.1002/mds.25966 · Cited by 43
Sánchez, M., Suárez, L., Andrés, M. T. A., Flórez, B. H., Bordallo, J., Riestra, S., & Cantabrana, B. (2017) · Food & Nutrition Research · doi:10.1080/16546628.2017.1321948 · Cited by 25
Beyond here be dragons: SIBO in Parkinson's disease
Pfeiffer, R. F. (2013) · Movement Disorders · doi:10.1002/mds.25705 · Cited by 22
Cited by
Small molecule metabolites: discovery of biomarkers and therapeutic targets
Qiu, S., Cai, Y., Yao, H., Lin, C., Xie, Y., Tang, S., & Zhang, A. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01399-3 · Cited by 884
Short chain fatty acids: Microbial metabolites for gut-brain axis signalling
O'Riordan, K. J., Collins, M. K., Moloney, G. M., Knox, E. G., Aburto, M. R., Fülling, C., Morley, S. J., Clarke, G., Schellekens, H., & Cryan, J. F. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111572 · Cited by 713
The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Tan, A. H., Lim, S. Y., & Lang, A. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00681-2 · Cited by 392
Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi‐Omics
Tan, A. H., Chong, C. W., Lim, S., Yap, I. K. S., Teh, C. S. J., Loke, M. F., Song, S., Tan, J. Y., Ang, B. H., Tan, Y. Q., et al. (2021) · Annals of Neurology · doi:10.1002/ana.25982 · Cited by 196
Nishiwaki, H., Hamaguchi, T., Ito, M., Ishida, T., Maeda, T., Kashihara, K., Tsuboi, Y., Ueyama, J., Shimamura, T., Mori, H., et al. (2020) · mSystems · doi:10.1128/msystems.00797-20 · Cited by 133
Metadata
- Authors
- Vascellari, S., Palmas, V., Melis, M., Pisanu, S., Cusano, R., Uva, P., Perra, D., Madau, V., Sarchioto, M., Oppo, V., Simola, N., Morelli, M., Santoru, M. L., Atzori, L., Melis, M., Cossu, G., & Manzin, A.
- Venue
- mSystems
- Publisher
- American Society for Microbiology
- Published
- 2020-10-27
- Volume
- 5
- Issue
- 5
- ISSN
- 2379-5077 (ISSN-L)
- OpenAlex
- W3085634769
- Cited by
- 286
- References
- 58
- FWCI
- 10.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.